Ambassador Advisors, LLC Repligen Corp Transaction History

Ambassador Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $293,641 - $361,101	-1,186 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$194.77 - $324.21 $171,787 - $285,953	-882 Reduced 42.65%	1,186 $342,000
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $1.63 Million - $2.17 Million	-9,838 Reduced 82.63%	2,068 $413,000
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $2.15 Million - $2.69 Million	11,906 New	11,906 $2.32 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Ambassador Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ambassador Advisors, LLC with notifications on news.